SHL Telemedicine reports third quarter and nine months 2011 results

Third Quarter highlights

  • Revenues of USD 10.2 million.
  • EBITDA of USD 2.3 million (22.5% of revenues).
  • EBIT of USD 1.1 million (10.8% of revenues).
  • Net income of USD 1.4 million (13.7% of revenues).
  • Dividend paid of USD 0.66 per share.
Tel Aviv/Zurich, 29 November 2011
SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, today announced results for the third quarter and nine months 2011.
Erez Alroy, Co-CEO of SHL Telemedicine, stated: “During the third quarter SHL’s business continued to operate as anticipated. In Germany we adapted our capacity to reflect reduced ongoing operations while making major steps forward in completing significant contracts with a number of healthcare insurers. The Israeli operations are continuing to provide a solid platform to produce satisfactory performance.”